Oncocyte Corporation Announces $10.2 Million Private Placement of Securities

Oncocyte Corporation has entered into a securities purchase agreement with new and existing investors, including Bio-Rad Laboratories, Inc. The company expects to receive approximately $10.2 million from the private placement, which will be used for working capital and general corporate purposes. This partnership demonstrates strong support from both current and new shareholders, including their corporate partner, Bio-Rad Laboratories, Inc.